Overview

LEAP2 on Postprandial Glucose Metabolism and Food Intake n Obese Males

Status:
Recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
The study aims to delineate the effects of the naturally occurring peptide liver-enriched antimicrobial peptide 2 (LEAP-2) on postprandial glucose metabolism and food intake in obese volunteers. The overall objective is to investigate the physiological importance of LEAP-2 in obese subjects.
Phase:
N/A
Details
Lead Sponsor:
University Hospital, Gentofte, Copenhagen